805 filings
10-Q
2024 Q1
VCEL
Vericel Corp
Quarterly report
8 May 24
8:59am
8-K
VCEL
Vericel Corp
8 May 24
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
8:10am
8-K
VCEL
Vericel Corp
3 May 24
Submission of Matters to a Vote of Security Holders
4:05pm
ARS
2023 FY
VCEL
Vericel Corp
21 Mar 24
Annual report to shareholders
7:45am
DEFA14A
VCEL
Vericel Corp
21 Mar 24
Additional proxy soliciting materials
7:32am
8-K
hzbwxgxjjwa0too2
29 Feb 24
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
8:04am
8-K
pjla897 8jortg
9 Jan 24
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
4:05pm
8-K
pgvxozjj 5bi
8 Nov 23
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
8:06am
8-K
5bhin5k9syzoyzc
20 Sep 23
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
4:31pm
8-K
n4xc0ez6bja8iosn
2 Aug 23
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
8:03am
S-8
5h2s7ee5tdyymio
22 May 23
Registration of securities for employees
4:06pm
8-K
eoflg3 gxyikfnp2
10 May 23
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
8:03am
8-K
mwv5v3s7bfzoq
5 May 23
Departure of Directors or Certain Officers
4:06pm
ARS
zks93343jriwk hz7xd
23 Mar 23
Annual report to shareholders
8:01am
DEFA14A
qkuex 97ej
23 Mar 23
Additional proxy soliciting materials
8:01am